WallStreetZenWallStreetZen

NASDAQ: RGLS
Regulus Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Regulus Therapeutics earnings were -$46.4M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest RGLS earnings report on Sep 30, 2026 announced Q3 2026 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, RGLS reported annual earnings of -$46.4M, with 54.3% growth. The next RGLS earnings date is May 7, 2025.

RGLS earnings history

Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%

RGLS Return on Equity

Current Company
N/A
Current Industry
19.9%
Current Market
35%
RGLS's Return on Equity (-50.3%)... subscribe to Premium to read more.
High Return on Equity Performance

RGLS undefined

Current Company
N/A
Current Industry
1.3%
RGLS is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when RGLS announces earnings.

RGLS undefined

Current Company
0%
Current Industry
14.3%
RGLS has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

RGLS vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
RGLS-$45.85M-$46.36MN/A-$0.82
ALDX-$53.68M-$55.85MN/A-$0.94
NKTX-$97.35M-$108.79MN/A-$1.60
LYEL-$323.36M-$342.99MN/A-$1.31
SCPH-$77.43M-$85.15MN/A-$1.91
View Top Biotech Stocks

RGLS earnings dates

Next earnings date
May 7, 2025

Regulus Therapeutics Earnings Reports & History FAQ

What were Regulus Therapeutics's earnings last quarter?

Regulus Therapeutics (NASDAQ: RGLS) reported Q3 2026 earnings per share (EPS) of N/A, up N/A year over year. Total RGLS earnings for the quarter were N/A. In the same quarter last year, Regulus Therapeutics's earnings per share (EPS) was -$0.21.

If you're new to stock investing, here's how to buy Regulus Therapeutics stock.

When does Regulus Therapeutics report earnings?

The next RGLS earnings call is Invalid Date. Add RGLS to your watchlist to be reminded of Regulus Therapeutics's next earnings date.

What was RGLS's earnings growth in the past year?

As of Regulus Therapeutics's earnings date in Q2 2025, Regulus Therapeutics's earnings has grown year over year. RGLS earnings in the past year totalled -$46.36 million.

Is Regulus Therapeutics profitable or losing money?

As of the last Regulus Therapeutics earnings report, Regulus Therapeutics is currently losing money. Regulus Therapeutics's net profit (also called net income) for the twelve months ending Sep 30, 2026 was N/A, a N/A decrease year over year.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.